Noxopharm

Noxopharm EBIT per Share

The EBIT per Share of Noxopharm (NOX.AX) as of Oct 19, 2026 is -0.02 AUD. In the previous year, EBIT per Share was -0.03 AUD — a change of -49.47% (higher).

EBIT per Share

-0.02AUD

YoY

-49.47%

Last updated:

EBIT per Share of Noxopharm is 2026 -0.02 AUD. EBIT per Share of Noxopharm was 2025 -0.03 AUD. It decreases by -49.47% higher compared to the previous year.

The Noxopharm EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-0.11 AUD
Jan 1, 2020
-0.02 AUD
Jan 1, 2021
-0.03 AUD
Jan 1, 2022
-0.08 AUD
Jan 1, 2023
-0.06 AUD
Jan 1, 2024
-0.03 AUD
Jan 1, 2025
-0.03 AUD
Jan 1, 2026
-0.02 AUD
The Noxopharm EBIT per Share history
YEAREBIT per ShareYoY
-0.02AUD-49.47%
-0.03AUD+28.09%
-0.03AUD-54.59%
-0.06AUD-30.73%
-0.08AUD+223.88%
-0.03AUD+13.19%
-0.02AUD-80.26%
-0.11AUD-27.20%
-0.16AUD+362.10%
-0.03AUD+233.56%
-0.01AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Noxopharm Stock analysis

What does Noxopharm do? Noxopharm Ltd, based in Castle Hill, Australia, operates in the Health Care sector, specializing in Biotechnology. The company focuses on researching and developing drugs for cancer and inflammation treatments, employing 1,000 full-time staff. It has three active drug development programs: Veyonda (Idronoxil), an adjuvant therapy for late-stage cancers, Chroma for oncology applications, and Sofra for inflammation and autoimmunity using oligonucleotide technology. Additionally, Noxopharm is conducting studies on NOX66 for COVID-19 treatment. Noxopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noxopharm stock

EBIT per Share of Noxopharm is -0.02 AUD in 2026.

EBIT per Share of Noxopharm changed from -0.03 AUD to -0.02 AUD, representing a -49.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Noxopharm since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Noxopharm

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Noxopharm